0.3
0.30 (-4.53%)
As of Jun 02, 2023
Bellicum Pharmaceuticals, Inc [BLCM]
Source:
Company Overview
We are a clinical stage biopharmaceutical company focused on discovering and developing novel, controllable cellular immunotherapies for the treatment of various forms of cancer. We are advancing CAR-T cell therapies, which are an innovative approach in which a patients or donors T cells are genetically modified to carry chimeric antigen receptors, or CARs. We are using our proprietary Chemical Induction of Dimerization, or CID, technology platform to engineer our product candidates with switch technologies that are designed to control components of the immune system in real time.
Country | United States |
Headquarters | houston, texas |
Phone Number | (832) 384-1100 |
Industry | manufacturing |
CEO | Richard A. Fair |
Website | www.bellicum.com |